Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
作者信息
Creagan E T, Ahmann D L, Schutt A J, Schaid D J
出版信息
Cancer Treat Rep. 1987 Jul-Aug;71(7-8):769-70.
PMID:3607788
Abstract
摘要
Zotero 插件